Telix stock trades at 8.45 euros on Lang & Schwarz Friday evening

ISIN: AU000000TLX2
Trading venue: Lang & Schwarz
Quote: 8.45 euros on November 6, 2026 at 8:19 p.m. CET
Business: Therapeutic and diagnostic radiopharmaceuticals

Published on 11/06/2026 at 20:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Telix develops therapeutic and diagnostic radiopharmaceuticals. Its stock was quoted in euros during Friday evening trading.

Telix investor context

Telix develops therapeutic and diagnostic radiopharmaceuticals for oncology and related medical applications.
The company had scheduled a Capital Markets Day for November 3, 2026.

Telix, AU000000TLX2, Illustration mit AI erstellt.

Telix Pharmaceuticals develops therapeutic and diagnostic radiopharmaceuticals, with oncology applications at the center of its business. The company had scheduled a Capital Markets Day for Tuesday, November 3, 2026, keeping product development and commercialization in focus for investors.

Friday evening trading snapshot

Telix stock traded at 8.45 euros on Lang & Schwarz at 8:19 p.m. CET on Friday, November 6, 2026.

Investors can follow the real-time quote of Telix stock. The evening quotation provides a current market reference while the next regular trading session will determine the subsequent exchange-based price formation.